Guardant Health, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Guardant Health, Inc. on July 7, 2022, covering events occurring on June 30, 2022. The filing primarily addresses corporate governance changes regarding the Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on personnel appointments rather than financial performance results.
Material Changes
- Board Expansion: The Board of Directors increased its size to eight members.
- New Appointment: Steve E. Krognes was appointed as a Class III director, effective June 30, 2022.
- Committee Assignments: Mr. Krognes was appointed Chair of the Audit Committee and a member of the Nominating and Corporate Governance Committee.
- Compensation: Mr. Krognes received Initial Awards consisting of a stock option and restricted stock unit, each valued at $362,500, with a modified grant date of August 9, 2022.
Outlook, Risks, and Commentary
The filing includes a standard indemnification agreement for Mr. Krognes. There are no reported arrangements or understandings regarding his selection, nor any reportable transactions under Item 404(a) of Regulation S-K. The filing references a press release dated July 7, 2022, for further details on the appointment.
Investor Verification Checklist
- Verify the full text of the indemnification agreement referenced in the Form S-1/A filed on September 18, 2018.
- Review the press release dated July 7, 2022 (Exhibit 99.1) for additional context on the appointment.
- Confirm the impact of the new Audit Committee Chair on future financial reporting oversight.
- Check subsequent filings for the actual issuance of the equity awards on August 9, 2022.